Biotech & pharma
Nanoscopic cages for big applications
20 Apr 2013
3D printer can build synthetic tissues
20 Apr 2013
A custom-built programmable 3D printer can create materials with several of the properties of living tissues, Oxford University scientists have demonstrated.
Modified bacteria could be used in vaccines
By By Sam Wong | 18 Apr 2013
After Dolly, Roslin researchers create GM-modified piglet
17 Apr 2013
The male piglet, Pig 26, was born last August, and had been genetically engineered with the smallest of DNA mutations - a single deletion of one out of the 3 billion chemical "letters" of its entire genome
Patterning graphene with DNA
By Anne Trafton, MIT News Office | 10 Apr 2013
Folded DNA templates allow researchers to precisely cut out graphene shapes, which could be used in electronic circuits.
'Sonic lasso' catches cells
10 Apr 2013
Academics have demonstrated for the first time that a “sonic lasso” can be used to grip microscopic objects, such as cells, and move them about.
Cancer biologists find DNA-damaging toxins in common plant-based foods
06 Apr 2013
Liquid smoke, black and green teas and coffee produced levels of cell DNA damage comparable to chemo drugs
Study offers new way to discover HIV vaccine targets
By By Anne Trafton, MIT News Office | 23 Mar 2013
Researchers spot molecular control switch for preterm lung disorders
By By Karen N. Peart | 22 Mar 2013
Researchers create tomatoes that mimic actions of good cholesterol
By By Rachel Champeau | 22 Mar 2013
Breaking down the Parkinson’s pathway
By By Anne Trafton, MIT News Office | 18 Mar 2013
Latest articles
Featured articles
The decoupling paradox: Why Wall Street keeps funding AI despite $100 oil
By Axel Miller | 11 May 2026
AI infrastructure stocks continue rallying despite $100 oil as investors bet on productivity gains and semiconductor demand in 2026.
Hybrid bonding gains attention as AI chip packaging demand grows
By Cygnus | 23 Apr 2026
Hybrid bonding is driving AI chip packaging demand as backend technologies gain importance in the semiconductor supply chain.
The agentic transition: how enterprises are scaling AI from pilot to profit
By Cygnus | 22 Apr 2026
AI has entered its execution era. Discover how companies like Valeo and Microsoft are scaling agentic AI systems—from copilots to autonomous workflows driving real business impact.
Post-splashdown: What Artemis II taught us about the ‘deep space wall’
By Axel Miller | 15 Apr 2026
Artemis II splashdown marks a breakthrough in deep space exploration. Discover AVATAR radiation data, Orion’s distance record, and insights shaping NASA’s 2028 Moon mission.
Can aviation go green? The multi-billion dollar race for sustainable fuel
By Cygnus | 10 Apr 2026
Airlines are racing to adopt sustainable aviation fuel, but limited supply and high costs challenge the future of green aviation.
The battery race: who will control the future of electric vehicles?
By Axel Miller | 08 Apr 2026
The global battery race is reshaping the electric vehicle industry, with China, the US, and Europe competing for control over supply chains and technology.
AI vs governments: Who controls the future of intelligence?
By Cygnus | 07 Apr 2026
Governments and AI companies like OpenAI and Anthropic are shaping the future of intelligence amid rising policy conflicts and global competition.
Strait of Hormuz: how one chokepoint controls the global economy
By Axel Miller | 06 Apr 2026
The Strait of Hormuz is a critical global chokepoint. Learn how disruptions impact oil prices, shipping, and the global economy.
The $2 trillion AI infrastructure race: Who will control global compute?
By Cygnus | 06 Apr 2026
AI spending is set to exceed $2 trillion in 2026, driving a global race in data centers, chips, and energy infrastructure.
